BE803553A - NEW DRUG ASSOCIATION - Google Patents

NEW DRUG ASSOCIATION

Info

Publication number
BE803553A
BE803553A BE134531A BE134531A BE803553A BE 803553 A BE803553 A BE 803553A BE 134531 A BE134531 A BE 134531A BE 134531 A BE134531 A BE 134531A BE 803553 A BE803553 A BE 803553A
Authority
BE
Belgium
Prior art keywords
new drug
drug association
association
new
drug
Prior art date
Application number
BE134531A
Other languages
French (fr)
Inventor
G Laber
E Schutze
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE803553A publication Critical patent/BE803553A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/70Nitro radicals
    • C07D307/71Nitro radicals attached in position 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/42Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms
    • C07D333/44Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms attached in position 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
BE134531A 1972-08-14 1973-08-13 NEW DRUG ASSOCIATION BE803553A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1200872 1972-08-14

Publications (1)

Publication Number Publication Date
BE803553A true BE803553A (en) 1974-02-13

Family

ID=4378980

Family Applications (1)

Application Number Title Priority Date Filing Date
BE134531A BE803553A (en) 1972-08-14 1973-08-13 NEW DRUG ASSOCIATION

Country Status (10)

Country Link
JP (1) JPS594401B2 (en)
AT (1) AT347172B (en)
BE (1) BE803553A (en)
DD (1) DD109186A5 (en)
DE (1) DE2340709C2 (en)
ES (1) ES417804A1 (en)
FR (1) FR2196157B1 (en)
GB (1) GB1442625A (en)
HU (1) HU167371B (en)
NL (1) NL7311001A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MW7087A1 (en) * 1986-10-03 1988-05-11 Hoffmann La Roche 1,3-disubstituted imidazolium salts
DE3722886A1 (en) * 1987-07-10 1989-01-19 Basf Ag METHOD FOR THE PRODUCTION OF (ALPHA), SS-SUBSTITUTED ACROLEINS AND NEW SUBSTITUTED ACROLEINS

Also Published As

Publication number Publication date
FR2196157A1 (en) 1974-03-15
AT347172B (en) 1978-12-11
JPS594401B2 (en) 1984-01-30
FR2196157B1 (en) 1978-07-28
ATA705973A (en) 1978-04-15
DD109186A5 (en) 1974-10-20
DE2340709C2 (en) 1983-12-22
DE2340709A1 (en) 1974-02-28
NL7311001A (en) 1974-02-18
AU5917673A (en) 1975-02-13
ES417804A1 (en) 1976-06-16
GB1442625A (en) 1976-07-14
JPS49124062A (en) 1974-11-27
HU167371B (en) 1975-09-27

Similar Documents

Publication Publication Date Title
SE383273C (en) STRENGGJUTNINGSANLEGGNING
BE808144A (en) DECALCOMANIES
BE794087A (en) POLYEPOXYDES
SE397612B (en) DISCHARGE
AT324072B (en) WENDELBOHREB
BE808337A (en) NEW TRIALKOXYAROYLDIAMINES
AT323930B (en) UNDERMATTRESS
BE805209A (en) NEW ANTIMYCOSIC COMPOSITION
BE793495A (en) NEW CONNECTION
CH539331A (en) counter
FI54770C (en) SPRUTANORDNING
BE760328A (en) NEW DRUG ASSOCIATION
BE807918A (en) NEW PENICILLINS
AT326702B (en) MICROCAPSULES
DE2213755B2 (en) MICROCAPSULES
SE389182B (en) ANGALSTRARE
BE795023A (en) NEW BENZYLPYRIMIDINES
BE802082A (en) NEW POROPHORE COMPOSITION
BR7308740D0 (en) PHARMACEUTICAL FORM
BE803553A (en) NEW DRUG ASSOCIATION
JPS4945710A (en) FUGOKASHINGOHEN KANSOCHI
BE808917A (en) NEW DRUG ASSOCIATION
AT322779B (en) BOOKBOARD
FI55863B (en) RENANDE TILLSATSKOMPOSITION FOER MOTORBRAENSLEN
FI55049C (en) RAOVARUBLANDNING FOER TVAETT- OCH RENGOERINGSMEDEL

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SANDOZ S.A.

Effective date: 19840813